JEL Stock Overview
Engages in the research, development, manufacture, and marketing of scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
JEOL Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥35.20 |
| 52 Week High | JP¥45.60 |
| 52 Week Low | JP¥26.40 |
| Beta | 1.14 |
| 11 Month Change | -1.68% |
| 3 Month Change | -12.44% |
| 1 Year Change | 20.55% |
| 33 Year Change | -43.68% |
| 5 Year Change | 64.49% |
| Change since IPO | 257.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| JEL | DE Electronic | DE Market | |
|---|---|---|---|
| 7D | 1.1% | 0.4% | -1.9% |
| 1Y | 20.5% | 6.2% | 12.3% |
Return vs Industry: JEL exceeded the German Electronic industry which returned 6.2% over the past year.
Return vs Market: JEL exceeded the German Market which returned 12.3% over the past year.
Price Volatility
| JEL volatility | |
|---|---|
| JEL Average Weekly Movement | 7.4% |
| Electronic Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: JEL's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: JEL's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1949 | 3,435 | Izumi Oi | www.jeol.co.jp |
JEOL Ltd. engages in the research, development, manufacture, and marketing of scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment worldwide. The company operates through three segments: Scientific and Measuring Instruments Business, Industrial Equipment Business, and the Medical Equipment Business. It provides transmission electron microscopes; scanning electron microscopes; nuclear resonance and mass spectrometer; x-ray fluorescence spectrometer; electron diffractometer; ion beam application equipment, including specimen preparation equipment and multibeam systems; instruments for microarea and surface analysis, such as electron probe micro analyzers, auger microprobes, and photoelectron spectrometers; magnetic resonance equipment, such as nuclear magnetic resonance and electron spin resonance spectrometers; electron beam lithography systems; electron microscope for semiconductors; and clinical chemistry analyzers.
JEOL Ltd. Fundamentals Summary
| JEL fundamental statistics | |
|---|---|
| Market cap | €1.78b |
| Earnings (TTM) | €146.22m |
| Revenue (TTM) | €1.11b |
12.2x
P/E Ratio1.6x
P/S RatioIs JEL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JEL income statement (TTM) | |
|---|---|
| Revenue | JP¥182.02b |
| Cost of Revenue | JP¥97.85b |
| Gross Profit | JP¥84.17b |
| Other Expenses | JP¥60.29b |
| Earnings | JP¥23.88b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 08, 2024
| Earnings per share (EPS) | 467.24 |
| Gross Margin | 46.24% |
| Net Profit Margin | 13.12% |
| Debt/Equity Ratio | 9.9% |
How did JEL perform over the long term?
See historical performance and comparison